Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose

PHASE4CompletedINTERVENTIONAL
Enrollment

465

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

June 30, 2014

Conditions
Meningococcal Disease
Interventions
BIOLOGICAL

Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate vaccine

Subjects received at day 1 a single dose of Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate vaccine.

Trial Locations (16)

40004

27 KY Pediatric Adult Research 201 South 5th Street, Suite 102, Bardstown

44121

33 Dr. Sender's and Associates 2054 South Green Road, Cleveland

68134

36 Meridian Clinical Research 3319 N. 107th Street, Omaha

70006

26 Benchmark Research 3800 Houma Blvd., Suite 345, Metairie

72205

83 AR Pediatric Clinical Research 500 South University, Ste. 200, Little Rock

72712

82 Children s Inv Research Prgm (ChIRP) 2900 Medical Center Parkway, Ste. 300, Bentonville

76135

31 Benchmark Research, Fort Worth 4504 Boat Club Rd., Suite 400A, Fort Worth

76904

25 Benchmark Research, San Angelo 3555 Knickerbocker Rd., San Angelo

84015

65 Westside Medical 1477 N 2000 W, Suite C, Clinton

84075

47 Wee Care Pediatrics 1792 W. 1700 S., Syracuse

84095

37 Copperview Medical Associates 3556 West 9800 South, South Jordan

84121

29 J. Lewis Research, Inc. 6360 South 3000 East, Ste. 100, Salt Lake City

30 J. Lewis Research, Inc. 6360 South 3000 East, Ste. 100, Salt Lake City

90241

32 Prem Health Research Center 9317 Firestone Blvd., Downey

99202

34 Rockwood Clinic P S 400 East Fifth Avenue, Spokane

99218

35 Rockwood Clinic-North Pediatrics 9001 N Country Homes Blvd, Spokane

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY